MaxCyte Inc. (MXCT)
MaxCyte Statistics
Share Statistics
MaxCyte has 106.32M shares outstanding. The number of shares has increased by 1.42% in one year.
| 106.32M |
| 1.42% |
| 0.52% |
| 69.07% |
| n/a |
| 3,026 |
| 0.34% |
Short Selling Information
The latest short interest is 3.83M, so 3.6% of the outstanding shares have been sold short.
| 3.83M |
| 3.6% |
| 3.62% |
| 3.42 |
Valuation Ratios
The PE ratio is -10.62 and the forward PE ratio is -7. MaxCyte's PEG ratio is -1.97.
| -10.62 |
| -7 |
| 11.29 |
| 1.8 |
| 2.11 |
| -14.91 |
| -1.97 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for MaxCyte.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 10.88, with a Debt / Equity ratio of 0.09.
| 10.88 |
| 10.32 |
| 0.09 |
| -0.39 |
| -0.62 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $338,833.33 |
| $-360,131.58 |
| 114 |
| 0.16 |
| 0.8 |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -55.49% in the last 52 weeks. The beta is 1.04, so MaxCyte's price volatility has been higher than the market average.
| 1.04 |
| -55.49% |
| 2.52 |
| 3.58 |
| 39.57 |
| 894,090 |
Income Statement
In the last 12 months, MaxCyte had revenue of 38.63M and earned -41.05M in profits. Earnings per share was -0.39.
| 38.63M |
| 31.53M |
| -51.2M |
| -41.05M |
| -46.41M |
| -51.2M |
| -0.39 |
Balance Sheet
The company has 27.88M in cash and 18.03M in debt, giving a net cash position of 9.85M.
| 27.88M |
| 18.03M |
| 9.85M |
| -216.85M |
| 229.96M |
| 143.01M |
Cash Flow
In the last 12 months, operating cash flow was -27.61M and capital expenditures -1.65M, giving a free cash flow of -29.26M.
| -27.61M |
| -1.65M |
| -29.26M |
| -0.28 |
Margins
Gross margin is 81.62%, with operating and profit margins of -132.54% and -106.29%.
| 81.62% |
| -132.54% |
| -106.29% |
| -106.29% |
| -120.14% |
| -132.54% |
| -75.75% |
Dividends & Yields
MXCT does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for MXCT is $9, which is 318.6% higher than the current price. The consensus rating is "Buy".
| $9 |
| 318.6% |
| Buy |
| 1 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 3.61 |
| 2 |